Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australian device legislation

This article was originally published in The Gray Sheet

Executive Summary

Therapeutics Goods Administration is working with the Medical Industry Association of Australia to hold a series of workshops in late May and early June to educate industry on the new regulatory framework slated for implementation as early as the second half of 2002, according to a 1TGA release. The Therapeutic Goods Amendment (Medical Devices) Bill 2002 and the Therapeutic Goods (Charges) Amendment Bill were passed by the Australian Parliament March 21. The framework set out in the bills is based on Global Harmonization Task Force guidelines (2"The Gray Sheet" Nov. 26, 2001, p. 18)...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT016359

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel